Refine Search
Article Categories
Strategy Tags
Geography Tags
-
Keep calm and buy corporate loans
5 years ago
Calm heads prevailed in 2018. Markets were volatile and risk retention was supposed to cause problems, but there was no need to panic and volumes went on to break records set in 2014 -
Europe adapts to harsher CLO climate
5 years ago
The European CLO market survived the financial crisis and ensuing risk retention obligations. Conditions remain tough, but we expect a 25% increase in the number of active managers -
Widening whisks market back to 2017
5 years ago
Right now, CLO volumes are healthy and the list of active managers is steadily growing. But with CLO liability spreads reverting to where they were a year ago, some issuers are a little nervous. -
Time to reprice? Then compare the market
5 years ago
CLOs no longer fizzle out. Instead, they go through multiple repricings, where, with stakes lower and deadlines tighter than when they were issued, their managers can try alternative arrangers -
Issuers excited by busy first quarter
6 years ago
After 13 months of compulsory risk retention for US CLOs, it seems that the simplified regulatory regime is already encouraging a host of CLOs from returnees and new entrants to the market
-
Who predicted $145 billion of issuance?
6 years ago
That went better than expected: US risk retention came in, and $145 billion of global new issuance later, it’s clear that CLOs aren’t disappearing. By Tanvi Gupta and Sam Robinson -
CLO managers return to new issues
6 years ago
The frenetic pace of refis and resets slowed in the third quarter as CLO managers – new and old – turned their attention to building assets -
CLO boom encourages new ideas
7 years ago
Volumes are up, spreads are down and risk retention is a doddle. That must mean it’s time to push the boat out and innovate -
Who cares about risk retention?
7 years ago
Managers watching CLO spreads reach their tightest levels since the crisis had little time to fret about US risk retention
Want all the latest news, comment, analysis and data?